
News|Articles|December 24, 2024
RECAP: 2024 Updates in the GLP-1 Space
Key Takeaways
Despite the explosion of public interest in these drugs, ongoing shortages and debates over compounding made access difficult.
Advertisement
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
How Pharmacists Can Close the Opioid Addiction Care Gap
2
US Measles Cases Climb, Raising Questions About Preparedness and Prevention
3
FDA Awards National Priority Voucher to Teclistamab Plus Daratumumab in Relapsed/Refractory Multiple Myeloma
4
The Return of Belantamab Mafodotin: Past Lessons, Present Promise, and Future Impact
5
















































































































































































































